Normal view MARC view ISBD view

Late relapse of testis cancer

In Urologic Clinics of North America
By: Ehrlich Y.
Contributor(s): Baniel J | edithr@clalit.org.il <edithr@clalit.org.il>.
Material type: materialTypeLabelArticleSeries: Vol 34 Issues 2.Publisher: 2007Description: 253-258.Subject(s): Israel | Alpha-fetoprotein | Chemotherapy | Germ-cell tumors | Testis cancer | DDC classification: In: Urologic Clinics of North AmericaSummary: Most relapses of germ-cell tumors occur within 2 years of initial treatment. In 2% to 4% of patients, relapse may occur later. The retroperitoneum is the primary site of late relapse, and alpha-fetoprotein is the predominant marker. These tumors are highly resistant to chemotherapy. Surgical resection is the preferred treatment. If the recurrent disease is inoperable, chemotherapy may be instituted, followed by resection of residual masses. Patients successfully managed for testis cancer need lifelong surveillance.
Tags from this library: No tags from this library for this title. Add tag(s)
Log in to add tags.
    average rating: 0.0 (0 votes)
Item type Current location Call number Status Date due Barcode
Articles Articles Tata Memorial Hospital
Available AR6925

Most relapses of germ-cell tumors occur within 2 years of initial treatment. In 2% to 4% of patients, relapse may occur later. The retroperitoneum is the primary site of late relapse, and alpha-fetoprotein is the predominant marker. These tumors are highly resistant to chemotherapy. Surgical resection is the preferred treatment. If the recurrent disease is inoperable, chemotherapy may be instituted, followed by resection of residual masses. Patients successfully managed for testis cancer need lifelong surveillance.

There are no comments for this item.

Log in to your account to post a comment.

Powered by Koha